No Data
No Data
Tianyu Biology: third quarter report 2024
Third Quarter Report 2024
Announcement of key operating data for the third quarter of 2024
Tianyu Biology (603717.SH): Intends to purchase 22.5% equity of its holding subsidiary Tianqian Food.
On October 14, Gelonhui announced that Tianti Biotech (603717.SH) plans to sign an Equity Transfer Agreement with its affiliate Tianti Yuan, purchasing 22.50% of the equity held by its controlling subsidiary Tianqian Food. To ensure the fairness, impartiality, and reasonableness of the transaction pricing, the company has engaged the United And Harmony Land and Real Estate Assets Appraisal Co., Ltd. (referred to as 'United And Harmony') qualified in securities, futures and related evaluation business, to evaluate the value of the shareholders' equity of the target company. According to the valuation report issued by United And Harmony, the value of all equity interests of the target company involved in the planned equity acquisition of Tianti Biotech.
2024 Semi-Annual Report
2024 Semi-Annual Report Summary